PRIMARY STUDY

Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications

Key Findings:  Dietary β-Caryophyllene may have therapeutic effects for use in treating insulin resistance, type 2 diabetes, obesity, hyperlipidemia, and diabetic complications.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  United Arab Emirates

Year of Pub:  2020


Cannabinoids Studied: 

Phytocannabinoid Source:  Not Applicable

Terpenes Studied:  ß-Caryophyllene

Route of Administration:  Oral (Ingestion)



Link to study